Omixon is a global biotechnology company that commercializes disruptive innovations specializing in targeted applications for Next Generation Sequencing (NGS). The Omixon Holotype HLA™ product combines a targeted HLA Assay and the Omixon HLA Twin™ software to deliver the most accurate high-resolution HLA genotyping available. Omixon maintains an active grant-funded research program and assists scientists and clinicians to analyze the most challenging genomic regions including HLA, KIR and ABO.
New Feature Highlights A new release of Omixon HLA Twin is now available. Major re-design has taken place to provide a simplified workspace while adding several new features and improvements. Top New Features in HLA Twin 1.1.2 Modified Dashboard similar to a …more
We are happy to introduce our new colleague, Faisal Mojaddidi, who’s originally from Afghanistan, and based in the US since an early age. Having a background in Psychology and Biology, Faisal is highly passionate about personalized medicine, and he will …more